Terapia nutricional enteral y parenteral en pacientes con diagnóstico de COVID-19 en UCI

Abstract

Background: There is evidence of a large number of cases of disease due to the spread of COVID-19, drawing attention to the malnutrition that is directly associated with exposure and prolonged stay in the Intensive Care Unit, triggering a Malnutrition Syndrome or Malnutrition due to Sarcopenia. Description of the article: Our main objective is to demonstrate, through a bibliographic review of the medical literature for the period 2020-2022, the contribution of enteral and parenteral nutrition in critically ill patients diagnosed with COVID-19 to rescue the benefits in the clinical evolution of the patient. in terms of mortality and hospital stay. Regarding the materials and methods, a bibliographic review study on enteral and parenteral nutrition was carried out, with a search approach in it and with the use of databases such as: PubMed, Lilacs, Scielo, Scopus, Web of Science, the search included the period from January 2020 to December 2022, Conclusion: Patients in critical condition due to COVID-19 are closely linked to a severe state of inflammation that is associated with a series of early and very aggressive acute myopathic processes that trigger higher caloric-protein intake, lower tolerance to nutritional therapy and hence muscle loss. It will be developed with this research that both patients with parenteral enteral nutrition and with a diagnosis of COVID-19 will trigger various clinical benefits by improving nutritional intake, less nosocomial infection, lower mortality in intensive care units and predisposition to functional improvement.